Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones as PDE9 inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8357688
APP PUB NO 20110319385A1
SERIAL NO

13254368

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones are useful as PDE9 inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ASTELLAS PHARMA INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Azami, Hidenori Tokyo, JP 15 174
Kaizawa, Hiroyuki Tokyo, JP 23 1168
Kamijo, Kazunori Tokyo, JP 9 270
Kubota, Hideki Tokyo, JP 33 546
Nomura, Takaho Tokyo, JP 3 56
Seo, Ryushi Tokyo, JP 17 270
Sugita, Mari Tokyo, JP 4 48
Tsuchiya, Kazuyuki Tokyo, JP 15 132
Yamamoto, Hirofumi Tokyo, JP 129 1386
Yamamoto, Satoshi Tokyo, JP 491 8176

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 22, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00